Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status

G Gunaydin, ME Gedik, S Ayan - Frontiers in chemistry, 2021 - frontiersin.org
Photodynamic therapy (PDT) has been used as an anti-tumor treatment method for a long
time and photosensitizers (PS) can be used in various types of tumors. Originally, light is an …

dPCR: a technology review

PL Quan, M Sauzade, E Brouzes - Sensors, 2018 - mdpi.com
Digital Polymerase Chain Reaction (dPCR) is a novel method for the absolute quantification
of target nucleic acids. Quantification by dPCR hinges on the fact that the random …

Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications

N Iqbal, N Iqbal - Molecular biology international, 2014 - Wiley Online Library
Human epidermal growth factor receptor 2 (HER2) is a member of the epidermal growth
factor receptor family having tyrosine kinase activity. Dimerization of the receptor results in …

Considerations for digital PCR as an accurate molecular diagnostic tool

JF Huggett, S Cowen, CA Foy - Clinical chemistry, 2015 - academic.oup.com
Abstract BACKGROUND Digital PCR (dPCR) is an increasingly popular manifestation of
PCR that offers a number of unique advantages when applied to preclinical research …

Phage display screening of therapeutic peptide for cancer targeting and therapy

PE Saw, EW Song - Protein & cell, 2019 - academic.oup.com
Recently, phage display technology has been announced as the recipient of Nobel Prize in
Chemistry 2018. Phage display technique allows high affinity target-binding peptides to be …

Tissue microarrays for high-throughput molecular profiling of tumor specimens

J Kononen, L Bubendorf, A Kallionimeni, M Bärlund… - Nature medicine, 1998 - nature.com
Many genes and signalling pathways controlling cell proliferation, death and differentiation,
as well as genomic integrity, are involved in cancer development. New techniques, such as …

HER2: biology, detection, and clinical implications

C Gutierrez, R Schiff - Archives of pathology & laboratory …, 2011 - meridian.allenpress.com
Context—HER2 is a membrane tyrosine kinase and oncogene that is overexpressed and
gene amplified in about 20% of breast cancers. When activated it provides the cell with …

The HER-2 receptor and breast cancer: ten years of targeted anti–HER-2 therapy and personalized medicine

JS Ross, EA Slodkowska, WF Symmans… - The …, 2009 - academic.oup.com
Learning Objectives Contrast the current strengths and limitations of the three main slide-
based techniques (IHC, FISH, and CISH) currently in clinical use for testing breast cancer …

HER2 in breast cancer: a review and update

U Krishnamurti, JF Silverman - Advances in anatomic pathology, 2014 - journals.lww.com
HER2 (human epidermal growth factor receptor 2) receptor is a membrane tyrosine kinase
and when activated affects cell proliferation and survival. The HER2 oncogene is located on …

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

MM Moasser - Oncogene, 2007 - nature.com
The year 2007 marks exactly two decades since Human Epidermal Growth Factor Receptor-
2 (HER2) was functionally implicated in the pathogenesis of human breast cancer. This …